The Dry Eye Syndrome Market is witnessing steady transformation as ophthalmology shifts toward more personalized and disease-focused approaches to dry eye management. Market Research Future estimates that the global market will increase from USD 6.80 billion in 2025 to USD 10.30 billion by 2035, reflecting a CAGR of 4.25% over the forecast period.

One major trend is the increasing adoption of prescription therapies, including anti-inflammatory and immunomodulatory treatments. These therapies are becoming more important for patients with moderate-to-severe or chronic dry eye conditions. At the same time, preservative-free eye drops, ointments, gels, and sustained-release delivery systems are attracting greater attention.

Digital eye strain is another important factor influencing demand. Increasing daily exposure to smartphones, computers, and other digital devices can contribute to ocular discomfort and tear-film instability. This is creating opportunities for diagnostic technologies and preventive eye-care solutions.

The market is also benefiting from advances in tele-ophthalmology and remote diagnostics. Digital healthcare platforms can improve access to eye-care professionals, particularly in underserved areas.

Asia-Pacific is expected to experience the fastest regional growth, while North America continues to represent a major revenue market. Online pharmacies are also projected to expand rapidly as digital purchasing and subscription-based refill models become more common.

Future opportunities are likely to emerge from AI-powered diagnostics, sustained-release therapies, combination treatment platforms, and personalized ophthalmic care.